Osteoporosis Kills More in Male Patients!

Bezmialem Vakıf University Faculty of Medicine Deputy Dean and Head of Physical Medicine and Rehabilitation Department Prof. Dr. Teoman Aydın made statements about osteoporosis, also known as "bone loss".

prof. Dr. Teoman Aydın stated that scientific studies have revealed that approximately one-third of men have a lifetime risk of osteoporosis-related fractures. Noting that one-third of all osteoporosis-related fractures are seen in men over the age of 50, Prof. Dr. Teoman Aydın stated that the risk of osteoporosis-related fracture and fracture-related death is 50-2 times higher in men over the age of 3 than in women.

prof. Dr. Teoman Aydın explains the risk factors for osteoporosis in men, "Genetic factors, advanced age, thin body structure, sedentary lifestyle, hormonal factors, alcohol and smoking, some drug treatments, especially cortisone and thyroid drugs, prostate cancer and antiandrogen (testosterone suppressant) ) being treated, insufficient dietary calcium intake, some surgeries involving the stomach and intestines”.

prof. Dr. Teoman Aydın said, “For the evaluation of individuals with risk factors for osteoporosis, some blood tests, measurement of calcium and vitamin D levels, bone density measurement (Dual Energy X-Ray Absorptiometry-DEXA) are required.”

prof. Dr. For the treatment of osteoporosis, Teoman Aydın said, “Adequate calcium intake in the diet, especially after 55-60 years of age, vitamin D support, lifelong regular exercise, diagnosis and effective treatment of testosterone hormone deficiency, if any, for the prevention and treatment of osteoporosis and the risk of fracture development in the bones related to it, Prevention of alcohol and cigarette consumption is extremely important. Medical treatment options such as bisphosphonates, bone density-increasing teriparatide, strontium, testosterone and denosumab, which are the drug group that should be selected according to the underlying problem and suitability for the patient, are used in male patients with osteoporosis, under the control of a physician.

Underlining that treatment and controls should not be interrupted, Prof. Dr. Teoman Aydın concluded his speech by stating that patients should be followed up with bone density measurement every 1-2 years.